1001426 - Tisagenlecleucel 1.2 x10e6 - 6 x10e8 células Disp inj Fr 50 ml IV

ID 13411234 · Portal BASE
Price
Base Price
€252,757 .00
Effective Price
€252,757 .00 0.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33000000
Location
Portugal, Porto, Porto
Bidder Count
—
Winner
NOVARTIS FARMA - PRODUTOS FARMACÊUTICOS S.A.
NIF 500063524
Company
Dates
Publication
13 Feb 2026
Celebration
06 Jan 2026
Contracting Entity
Instituto Português de Oncologia do Porto Francisco Gentil, E. P. E.
NIF 506362299
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 40 · MEDIUM RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
13 Feb 2026
Signing Date
06 Jan 2026
Days Late
38
Rule
A2/A3 late publication: 38 days after signing (threshold: 10)
Detected 2026-03-06